[HTML][HTML] Antiviral drug discovery: preparing for the next pandemic
Clinically approved antiviral drugs are currently available for only 10 of the more than 220
viruses known to infect humans. The SARS-CoV-2 outbreak has exposed the critical need …
viruses known to infect humans. The SARS-CoV-2 outbreak has exposed the critical need …
Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019
A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …
SARS-CoV-2: recent reports on antiviral therapies based on lopinavir/ritonavir, darunavir/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for …
M Costanzo, MAR De Giglio… - Current medicinal …, 2020 - ingentaconnect.com
Here we report on the most recent updates on experimental drugs successfully employed in
the treatment of the disease caused by SARS-CoV-2 coronavirus, also referred to as COVID …
the treatment of the disease caused by SARS-CoV-2 coronavirus, also referred to as COVID …
Convalescent plasma therapy for COVID-19: state of the art
Convalescent plasma (CP) therapy has been used since the early 1900s to treat emerging
infectious diseases; its efficacy was later associated with the evidence that polyclonal …
infectious diseases; its efficacy was later associated with the evidence that polyclonal …
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
A Pandey, AN Nikam, AB Shreya, SP Mutalik… - Life sciences, 2020 - Elsevier
The present pandemic of SARS-CoV-2 has been a tough task for the whole world to deal
with. With the absence of specific drugs or vaccines against SARS-CoV-2, the situation is …
with. With the absence of specific drugs or vaccines against SARS-CoV-2, the situation is …
[HTML][HTML] Antivirals with common targets against highly pathogenic viruses
Historically, emerging viruses appear constantly and have cost millions of human lives.
Currently, climate change and intense globalization have created favorable conditions for …
Currently, climate change and intense globalization have created favorable conditions for …
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
C Liang, L Tian, Y Liu, N Hui, G Qiao, H Li, Z Shi… - European journal of …, 2020 - Elsevier
Abstract Remdesivir (GS-5734), a viral RNA-dependent RNA polymerase (RdRP) inhibitor
that can be used to treat a variety of RNA virus infections, is expected to be an effective …
that can be used to treat a variety of RNA virus infections, is expected to be an effective …
[HTML][HTML] Recent advances in carbon quantum dots for virus detection, as well as inhibition and treatment of viral infection
In the last decade, carbon quantum dots (CQDs), as a novel class of carbon-based
nanomaterials, have received increasing attention due to their distinct properties. CQDs are …
nanomaterials, have received increasing attention due to their distinct properties. CQDs are …
[HTML][HTML] Drug discovery strategies for SARS-CoV-2
Coronavirus disease 2019 (COVID-19) is a novel disease caused by the severe acute
respiratory syndrome coronavirus (SARS-CoV)-2 virus that was first detected in December of …
respiratory syndrome coronavirus (SARS-CoV)-2 virus that was first detected in December of …